Maria L Padilla

Summary

Affiliation: Mount Sinai School of Medicine
Country: USA

Publications

  1. ncbi Donor-acquired sarcoidosis
    Maria L Padilla
    Mount Sinai Medical Center, Division of Pulmonary and Critical Care Medicine, New York, NY 10029, USA
    Sarcoidosis Vasc Diffuse Lung Dis 19:18-24. 2002
  2. ncbi Spectrum of fibrosing diffuse parenchymal lung disease
    Adam S Morgenthau
    Division of Pulmonary, Critical Care, and Sleep Medicine, Mount Sinai School of Medicine, New York, NY, USA
    Mt Sinai J Med 76:2-23. 2009
  3. ncbi Distinctive clinical, radiographic, and functional characteristics of patients with sarcoidosis-related pulmonary hypertension
    Roxana Sulica
    Pulmonary, Critical Care, and Sleep Division, Mount Sinai Medical Center, One Gustave L. Levy Place, Box 1232, New York, NY 10029, USA
    Chest 128:1483-9. 2005
  4. ncbi Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis
    Alvin S Teirstein
    Divisions of Pulmonary Medicine, Mount Sinai Medical Center, New York, NY, USA
    Chest 132:1949-53. 2007
  5. ncbi Cardiac sarcoidosis
    Uma S Ayyala
    Division of Pulmonary and Critical Care Medicine, Mount Sinai Medical Center, One Gustave L Levy Place, New York, NY 10029, USA
    Clin Chest Med 29:493-508, ix. 2008
  6. ncbi Sarcoidosis presenting in patients older than 50 years
    Roberta Lenner
    Department of Pulmonary and Critical Care Medicine, Mount Sinai NYU Medical Center, New York, NY, USA
    Sarcoidosis Vasc Diffuse Lung Dis 19:143-7. 2002
  7. ncbi Diagnosis and treatment of hepatic sarcoidosis
    Uma S Ayyala
    Mount Sinai Medical Center, One Gustave L Levy Place, Box 1232, New York, NY 10029 6574, USA
    Curr Treat Options Gastroenterol 9:475-83. 2006
  8. ncbi Idiopathic pleuroparenchymal fibroelastosis: an unrecognized or misdiagnosed entity?
    Christian D Becker
    Department of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, The Mount Sinai School of Medicine, New York, NY 10029, USA
    Mod Pathol 21:784-7. 2008
  9. ncbi Cardiac sarcoidosis
    Alvin S Teirstein
    Chest 129:1113. 2006

Collaborators

Detail Information

Publications9

  1. ncbi Donor-acquired sarcoidosis
    Maria L Padilla
    Mount Sinai Medical Center, Division of Pulmonary and Critical Care Medicine, New York, NY 10029, USA
    Sarcoidosis Vasc Diffuse Lung Dis 19:18-24. 2002
    ..Issues underlying host tolerance as a possible explanation for the reported absence of mortality or loss of allograft function during the limited periods of observation are also discussed...
  2. ncbi Spectrum of fibrosing diffuse parenchymal lung disease
    Adam S Morgenthau
    Division of Pulmonary, Critical Care, and Sleep Medicine, Mount Sinai School of Medicine, New York, NY, USA
    Mt Sinai J Med 76:2-23. 2009
    ..Although much has been learned about the diffuse parenchymal lung diseases during the past decade, research in these diseases is urgently needed...
  3. ncbi Distinctive clinical, radiographic, and functional characteristics of patients with sarcoidosis-related pulmonary hypertension
    Roxana Sulica
    Pulmonary, Critical Care, and Sleep Division, Mount Sinai Medical Center, One Gustave L. Levy Place, Box 1232, New York, NY 10029, USA
    Chest 128:1483-9. 2005
    ..CONCLUSIONS: The presence of pulmonary hypertension in patients with sarcoidosis is associated with higher prevalence of stage 4 sarcoidosis by CXR and lower predicted spirometric and D(LCO)sb measurements...
  4. ncbi Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis
    Alvin S Teirstein
    Divisions of Pulmonary Medicine, Mount Sinai Medical Center, New York, NY, USA
    Chest 132:1949-53. 2007
    ..To study the role of whole-body 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) scans in the identification of occult biopsy sites and reversible granulomatous disease in patients with sarcoidosis...
  5. ncbi Cardiac sarcoidosis
    Uma S Ayyala
    Division of Pulmonary and Critical Care Medicine, Mount Sinai Medical Center, One Gustave L Levy Place, New York, NY 10029, USA
    Clin Chest Med 29:493-508, ix. 2008
    ..Risk stratification for sudden cardiac death is essential in otherwise asymptomatic patients who have suspected cardiac sarcoidosis...
  6. ncbi Sarcoidosis presenting in patients older than 50 years
    Roberta Lenner
    Department of Pulmonary and Critical Care Medicine, Mount Sinai NYU Medical Center, New York, NY, USA
    Sarcoidosis Vasc Diffuse Lung Dis 19:143-7. 2002
    ....
  7. ncbi Diagnosis and treatment of hepatic sarcoidosis
    Uma S Ayyala
    Mount Sinai Medical Center, One Gustave L Levy Place, Box 1232, New York, NY 10029 6574, USA
    Curr Treat Options Gastroenterol 9:475-83. 2006
    ..Overall, treatment for hepatic sarcoidosis is targeted toward alleviation of symptoms but has no curative potential at this time. Focus should be on discovering the etiology of the disease to target therapy at prevention, not cure...
  8. ncbi Idiopathic pleuroparenchymal fibroelastosis: an unrecognized or misdiagnosed entity?
    Christian D Becker
    Department of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, The Mount Sinai School of Medicine, New York, NY 10029, USA
    Mod Pathol 21:784-7. 2008
    ..Only with better understanding of this disease can we hope in the future to be able to offer treatments other than supportive care and ultimately lung transplantation, which are the only therapeutic options available today...
  9. ncbi Cardiac sarcoidosis
    Alvin S Teirstein
    Chest 129:1113. 2006